Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP on Nasdaq, is the post-combination public company formed through the merger of Power Up Acquisition Corp., a blank-check SPAC that completed its initial public offering in 2021, with Aspire Biopharma. Targeting the biopharmaceutical sector, the company filed a Form 10-Q with the Securities and Exchange Commission on May 11, 2023, reflecting its ongoing quarterly reporting obligations as a post-merger operating entity. The filing, carrying accession number 0001410578-23-001031, documents the company's financial position in the life sciences space following the close of its SPAC transaction. Sign up at SpacDesk for full data on PWUP, including complete filing history and deal analytics.